Ablation of Anal Lesions. (Clinical Capsules).
Ablative surgery was used to treat large-volume anal high-grade squamous intraepithelial lesions (HSIL) in 37 men, including 29 who had HIV in this prospective safety study. After Lugol's solution was applied to the anal area, high-resolution anoscopy was used to identify tissue with HSIL for incisional biopsy followed by electrocautery ablation; patients with circumferential disease had a staged procedure to preserve perianal skin.
Uncontrolled pain of a mean duration of 3 weeks was reported by 16 of the 29 men who completed a telephone survey in the weeks after their surgery. No patient reported stenosis, incontinence, abscess, or bleeding; 21 of the 24 men who had practiced receptive anal intercourse before surgery were able to resume receptive anal intercourse after an average of 6 months (Dis. Colon Rectum 45:453-58, 2002).
There was no recurrence of HSIL in the eight HIV-negative men during follow-up. However, HSIL recurred in 23 of the 29 HIV-positive men, with a mean time to recurrence of 12 months.
|Printer friendly Cite/link Email Feedback|
|Author:||Kubetin, Sally Koch|
|Publication:||Internal Medicine News|
|Article Type:||Brief Article|
|Date:||Apr 15, 2002|
|Previous Article:||Quality of life, HCV therapy. (Clinical Capsules).|
|Next Article:||Colon Cancer Survival. (Clinical Capsules).|
|Ovarian Ablation, Suppression May Aid Ca Therapy.|
|Postpartum anal lesions. (Clinical Capsules).|
|Biopsy anal canal lesions for cancer. (Can be of Mixed Pathology).|